Amyloid beta-protein (1-43) and Amyloid beta-protein (1-39) polypeptides are the primary constituents of senile plaques and cerbrovascular deposits in Alzheimer’s disease and Down’s syndrome. Goldgaber, D.; et al., Science, 235, 877, (1987); Pike, C.J.; et al., J. Neurosci., 13, 1676, (1993); Gregori, L.; et al., J. Biol. Chem., 270, 19702, (1995).
MW: 4615.24